冠状动脉生理学阈值与心肌梗死微血管阻塞的关联
该前瞻性多中心研究纳入102例ST段抬高型心肌梗死(STEMI)患者,在直接经皮冠状动脉介入治疗后测量靶血管的冠状动脉血流储备(CFR)和微血管阻力指数(IMR)。结果显示IMR>31单位且CFR≤1.25与微血管阻塞高患病率、较低左心室射血分数及较大梗死面积和危险区域相关。
要点
- IMR>31单位且CFR≤1.25提示微血管阻塞风险显著增高。
- 该阈值组合患者左心室射血分数更低、梗死面积更大。
- 术后即刻生理学评估有助于识别微血管阻塞高危患者。
核心结论
- IMR和CFR与STEMI患者微血管阻塞的存在相关。
- IMR>31单位且CFR≤1.25的患者微血管阻塞患病率更高、左心室射血分数更低、梗死面积和危险区域更大。
研究设计与样本
- 在成功直接经皮冠状动脉介入治疗后即刻测量靶血管的CFR和IMR,并估算预测微血管阻塞的最佳截断值。
主要发现
- IMR>31单位且CFR≤1.25预测微血管阻塞的准确性最佳。
- 与IMR≤31且CFR>1.25的患者相比,IMR>31且CFR≤1.25者微血管阻塞患病率更高(83% vs 38%,p<0.001),左心室射血分数更低(45±9% vs 52±9%,p=0.043)。
- IMR>31且CFR≤1.25者左心室射血分数低于CFR≤1.25且IMR≤31者(45±9% vs 54±7%,p=0.025)。
- IMR>31且CFR≤1.25者梗死面积和危险区域较其他组更大。
关键数值与推荐
- IMR>31单位且CFR≤1.25为预测微血管阻塞的最佳截断值组合。
- 微血管阻塞患病率在IMR>31且CFR≤1.25组为83%,在IMR≤31且CFR>1.25组为38%(p<0.001)。
- 左心室射血分数在IMR>31且CFR≤1.25组为45±9%,在IMR≤31且CFR>1.25组为52±9%(p=0.043)。
- 左心室射血分数在IMR>31且CFR≤1.25组为45±9%,在CFR≤1.25且IMR≤31组为54±7%(p=0.025)。
临床怎么用
- STEMI患者直接PCI术后可考虑即刻测量IMR和CFR以评估微血管阻塞风险。
- IMR>31单位且CFR≤1.25提示需加强微血管阻塞的监测与干预。
局限性
- 样本量较小(102例),仅来自意大利五家中心。
- 未报告长期临床结局的随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To ascertain whether invasive assessment of coronary physiology soon after recanalisation of the culprit artery by primary percutaneous coronary intervention is associated with the development of microvascular obstruction by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction (STEMI). METHODS: Between November 2020 and December 2021, 102 consecutive patients were prospectively enrolled in five tertiary centres in Italy. Coronary flow reserve (CFR) and index of microvascular resistance (IMR) were measured in the culprit vessel soon after successful primary percutaneous coronary intervention. Optimal cut-off points of IMR and CFR to predict the presence of microvascular obstruction were estimated, stratifying the population accordingly in four groups. A comparison with previously proposed stratification models was carried out. RESULTS: IMR>31 units and CFR≤1.25 yielded the best accuracy. Patients with IMR>31 and CFR≤1.25 exhibited higher microvascular obstruction prevalence (83% vs 38%, p<0.001) and lower left ventricular ejection fraction (45±9% vs 52±9%, p=0.043) compared with those with IMR≤31 and CFR>1.25, and lower left ventricular ejection fraction compared with patients with CFR≤1.25 and IMR≤31 (45±9% vs 54±7%, p=0.025). Infarct size and area at risk were larger in the former, compared with other groups. CONCLUSIONS: IMR and CFR are associated with the presence of microvascular obstruction in STEMI. Patients with an IMR>31 units and a CFR≤1.25 have higher prevalence of microvascular obstruction, lower left ventricular ejection fraction, larger infarct size and area at risk. TRIAL REGISTRATION NUMBER: NCT04677257.
引用
- Benenati, Montorfano, Pica, et al. Coronary physiology thresholds associated with microvascular obstruction in myocardial infarction. Heart. 2024. PMID: 37879880. doi:10.1136/heartjnl-2023-323169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。